Jasper Therapeutics
JSPR
JSPR
79 hedge funds and large institutions have $275M invested in Jasper Therapeutics in 2024 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 23 increasing their positions, 20 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.67% more ownership
Funds ownership: 96.47% → 97.13% (+0.67%)
17% less capital invested
Capital invested by funds: $330M → $275M (-$55M)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
79
Holding in Top 10
4
Calls
$3.39M
Puts
$1.4M
Top Buyers
| 1 | +$9.09M | |
| 2 | +$6.58M | |
| 3 | +$4.82M | |
| 4 |
ABG
Ally Bridge Group
New York
|
+$3.4M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$2.66M |
Top Sellers
| 1 | -$17.8M | |
| 2 | -$6.53M | |
| 3 | -$4.98M | |
| 4 |
SC
Stempoint Capital
New York
|
-$3.26M |
| 5 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$2.49M |